Free Trial

Keefe, Bruyette & Woods Issues Positive Forecast for Bowhead Specialty (NYSE:BOW) Stock Price

Bowhead Specialty logo with Finance background

Bowhead Specialty (NYSE:BOW - Free Report) had its price target increased by Keefe, Bruyette & Woods from $36.00 to $44.00 in a research report report published on Friday,Benzinga reports. Keefe, Bruyette & Woods currently has a market perform rating on the stock.

Other equities research analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. raised their price objective on shares of Bowhead Specialty from $26.00 to $30.00 and gave the stock a "neutral" rating in a research note on Thursday, November 7th. JMP Securities lifted their price objective on shares of Bowhead Specialty from $32.00 to $33.00 and gave the company a "market outperform" rating in a report on Wednesday, November 6th. Finally, Royal Bank of Canada increased their target price on shares of Bowhead Specialty from $32.00 to $35.00 and gave the stock an "outperform" rating in a research note on Wednesday, November 6th. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Bowhead Specialty has a consensus rating of "Hold" and a consensus price target of $33.60.

Get Our Latest Stock Analysis on BOW

Bowhead Specialty Stock Up 0.0 %

Shares of BOW stock traded up $0.01 during mid-day trading on Friday, reaching $31.84. The stock had a trading volume of 117,456 shares, compared to its average volume of 150,626. Bowhead Specialty has a 1-year low of $22.14 and a 1-year high of $37.81. The business's fifty day moving average is $34.47 and its 200-day moving average is $30.39.

Bowhead Specialty (NYSE:BOW - Get Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.38 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.38. The business had revenue of $116.76 million for the quarter, compared to analysts' expectations of $113.00 million. Equities analysts expect that Bowhead Specialty will post 1.38 earnings per share for the current year.

Insider Buying and Selling

In other Bowhead Specialty news, Director Family Mutual Insuran American sold 1,362,285 shares of the firm's stock in a transaction on Friday, October 25th. The stock was sold at an average price of $27.70, for a total value of $37,735,294.50. Following the completion of the sale, the director now directly owns 4,700,761 shares of the company's stock, valued at $130,211,079.70. This trade represents a 22.47 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Hedge Funds Weigh In On Bowhead Specialty

Several institutional investors and hedge funds have recently bought and sold shares of BOW. TD Asset Management Inc purchased a new stake in shares of Bowhead Specialty during the 2nd quarter valued at approximately $265,000. Victory Capital Management Inc. acquired a new stake in shares of Bowhead Specialty during the 2nd quarter worth about $15,973,000. American Century Companies Inc. purchased a new stake in Bowhead Specialty in the 2nd quarter valued at about $23,148,000. Rathbones Group PLC purchased a new stake in Bowhead Specialty in the 2nd quarter valued at about $266,000. Finally, Sei Investments Co. acquired a new position in Bowhead Specialty in the second quarter valued at about $2,021,000.

About Bowhead Specialty

(Get Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Featured Stories

Analyst Recommendations for Bowhead Specialty (NYSE:BOW)

Should You Invest $1,000 in Bowhead Specialty Right Now?

Before you consider Bowhead Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.

While Bowhead Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Transportation Stocks to Watch in 2025: Top Picks for Growth
Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines